Skip to content
2000
Volume 18, Issue 15
  • ISSN: 1568-0266
  • E-ISSN: 1873-4294

Abstract

Leishmaniasis is a neglected disease caused by protozoan belonging to the Leishmania genus. There are at least 16 pathogenic species for humans that are able to cause different clinical forms, such as cutaneous or visceral leishmaniasis. In spite of the different species and clinical forms, the treatment is performed with few drug options that, in most cases, are considered outdated. In addition, patients under classical treatment show serious side effects during drug administration, moreover parasites are able to become resistant to medicines. Thus, it is believed and well accepted that is urgent and necessary to develop new therapeutic options to overpass these concerns about conventional therapy of leishmaniasis. The present review will focus on the efficacy, side effects and action mechanism of classic drugs used in the treatment of leishmaniasis, as well as the importance of traditional knowledge for directing a rational search toward the discovery and characterization of new and effective molecules (in vivo assays) from plants to be used against leishmaniasis.

Loading

Article metrics loading...

/content/journals/ctmc/10.2174/1568026618666181002114448
2018-06-01
2025-06-21
Loading full text...

Full text loading...

/content/journals/ctmc/10.2174/1568026618666181002114448
Loading

  • Article Type:
    Review Article
Keyword(s): Amphotericin; Conventional drugs; Ethnopharmacology; Leishmaniasis; Molecules; New drugs
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test